Havea Group is a leading European natural healthcare player featuring a unique consumer/patient-centric approach centered on 5 strategic brands: Aragan, Biolane, Densmore, Dermovitamina and Vitavea. The Group and its brands help consumers prevent and treat common health issues with premium natural healthcare products. Powered by innovation and with a focus on sustainability - both at the core of Havea’s DNA - the company enables consumers to improve their quality of life.
We invested in Havea in 2017 and supported its transformation to become a leader in its sector and double in size. During this period, Havea delivered double-digit organic growth and completed 5 acquisitions in 5 years, significantly reinforcing its presence in Italy (largest European food supplements market) and Belgium. In addition, the company simplified its brand portfolio by moving to a consumer/patient-centric approach and implemented a complete multichannel strategy with for example the launch of D2C subscription services.
“Our partnership with 3i has been very successful. With their active support, Havea has grown substantially and established its leadership position in natural healthcare. We have laid all the right foundations to become the reference player, with a continued focus on improving our consumers’ quality of life with natural products. Partnering with BC Partners, which has extensive experience in fostering portfolio companies’ potential, would be a great opportunity. We share a common vision of the winning strategy to accelerate our development on a larger scale and become the undisputed European leader.” Nicolas Brodetsky, CEO, Havea